secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2025-03-13T23:59:59+00:00
Accession:  0001739410-25-000041
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rallybio reduces ATM offering cap from $100M to $9.55M under Sales Agreement with TD Cowen
--------------------------------------------------------------------------------

- Amendment reduces aggregate offering price from $100,000,000 to $9,550,000.
- As of March 13, 2025, no shares have been sold under the Sales Agreement.
- TD Cowen receives up to 3.0% commission on gross proceeds in at-the-market sales.
- Sales limited by public float rule: cannot exceed one-third of non-affiliate market value if public float <$75M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000173941025000041/0001739410-25-000041-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000173941025000041/rlyb-20250313.htm
  HTML page:      https://secwatch.observer/filing/0001739410-25-000041

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer